These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 3107041)

  • 1. Facilitation of latent inhibition by haloperidol in rats.
    Weiner I; Feldon J
    Psychopharmacology (Berl); 1987; 91(2):248-53. PubMed ID: 3107041
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The latent inhibition model of schizophrenic attention disorder. Haloperidol and sulpiride enhance rats' ability to ignore irrelevant stimuli.
    Feldon J; Weiner I
    Biol Psychiatry; 1991 Apr; 29(7):635-46. PubMed ID: 2054435
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phencyclidine does not disrupt latent inhibition in rats: implications for animal models of schizophrenia.
    Weiner I; Feldon J
    Pharmacol Biochem Behav; 1992 Aug; 42(4):625-31. PubMed ID: 1513845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haloperidol- and clozapine-induced enhancement of latent inhibition with extended conditioning: implications for the mechanism of action of neuroleptic drugs.
    Weiner I; Shadach E; Barkai R; Feldon J
    Neuropsychopharmacology; 1997 Jan; 16(1):42-50. PubMed ID: 8981387
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Latent inhibition is not affected by acute or chronic administration of 6 mg/kg dl-amphetamine.
    Weiner I; Izraeli-Telerant A; Feldon J
    Psychopharmacology (Berl); 1987; 91(3):345-51. PubMed ID: 3104957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abolition of the acquisition but not the expression of latent inhibition by chlordiazepoxide in rats.
    Feldon J; Weiner I
    Pharmacol Biochem Behav; 1989 Jan; 32(1):123-7. PubMed ID: 2734324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Facilitation of the expression but not the acquisition of latent inhibition by haloperidol in rats.
    Weiner I; Feldon J; Katz Y
    Pharmacol Biochem Behav; 1987 Feb; 26(2):241-6. PubMed ID: 3575349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Haloperidol-induced potentiation of latent inhibition: interaction with parameters of conditioning.
    Ruob C; Weiner I; Feldon J
    Behav Pharmacol; 1998 May; 9(3):245-53. PubMed ID: 9832938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amphetamine-induced disruption and haloperidol-induced potentiation of latent inhibition depend on the nature of the stimulus.
    Ruob C; Elsner J; Weiner I; Feldon J
    Behav Brain Res; 1997 Oct; 88(1):35-41. PubMed ID: 9401706
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A neuroleptic-like effect of ceronapril on latent inhibition.
    Weiner I; Smith AD; Rawlins JN; Feldon J
    Neuroscience; 1992 Jul; 49(2):307-15. PubMed ID: 1359453
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nicotine blocks latent inhibition in rats: evidence for a critical role of increased functional activity of dopamine in the mesolimbic system at conditioning rather than pre-exposure.
    Joseph MH; Peters SL; Gray JA
    Psychopharmacology (Berl); 1993; 110(1-2):187-92. PubMed ID: 7870882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systemic administration of MK-801 produces an abnormally persistent latent inhibition which is reversed by clozapine but not haloperidol.
    Gaisler-Salomon I; Weiner I
    Psychopharmacology (Berl); 2003 Apr; 166(4):333-42. PubMed ID: 12599023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antagonism of amphetamine-induced disruption of latent inhibition in rats by haloperidol and ondansetron: implications for a possible antipsychotic action of ondansetron.
    Warburton EC; Joseph MH; Feldon J; Weiner I; Gray JA
    Psychopharmacology (Berl); 1994 May; 114(4):657-64. PubMed ID: 7855229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of microinjections of apomorphine and haloperidol into the inferior colliculus on the latent inhibition of the conditioned emotional response.
    Melo LL; Pereira EC; Pagini CH; Coimbra NC; Brandão ML; Ferrari EA
    Exp Neurol; 2009 Mar; 216(1):16-21. PubMed ID: 19084523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sigma ligand BMY-14802 as a potential antipsychotic: evidence from the latent inhibition model in rats.
    Weiner I; Traub A; Rawlins JN; Smith AD; Feldon J
    Behav Pharmacol; 1995 Jan; 6(1):46-54. PubMed ID: 11224311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Basolateral amygdala lesions do not disrupt latent inhibition.
    Weiner I; Tarrasch R; Feldon J
    Behav Brain Res; 1995 Dec; 72(1-2):73-81. PubMed ID: 8788859
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early handling and latent inhibition in the conditioned suppression paradigm.
    Weiner I; Feldon J; Ziv-Harris D
    Dev Psychobiol; 1987 Mar; 20(2):233-40. PubMed ID: 3582782
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of the new antipsychotic, sertindole, on latent inhibition in rats.
    Weiner I; Kidron R; Tarrasch R; Arnt J; Feldon J
    Behav Pharmacol; 1994 Apr; 5(2):119-124. PubMed ID: 11224259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Disruption of latent inhibition by acute administration of low doses of amphetamine.
    Weiner I; Lubow RE; Feldon J
    Pharmacol Biochem Behav; 1988 Aug; 30(4):871-8. PubMed ID: 3227035
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Abolition of the expression but not the acquisition of latent inhibition by chronic amphetamine in rats.
    Weiner I; Lubow RE; Feldon J
    Psychopharmacology (Berl); 1984; 83(2):194-9. PubMed ID: 6431473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.